BioTrinity - Keep me informed
2008-10-11T21:24:10Z
BioTrinity - Keep me informed List Owner
jon.rees@oxfordshirebioscience.net
http://www.biotrinity.com/cgi-bin/dada/mail.cgi
Dada Mail 3.0.0 beta 3 - 05/19/08
Hold the Date for BioTrinity 2009: UK's Premier Biotechnology and Investment conference - early registration opens
tag:www.biotrinity.com,2008-09-04:%2Fcgi-bin%2Fdada%2Fmail.cgi%2Farchive%2Fpremarketing%2F20080904093936%2F
2008-09-04T09:39:36Z
2008-09-04T09:39:36Z
<TABLE cellSpacing=0 cellPadding=0 width=550 align=center bgColor=#020a27>
<TBODY>
<TR>
<TD height=25 ALIGN="middle" COLSPAN=2>
<DIV align=center><A href="http://www.biotrinity.com/2009/BioTrinity_Hold_the_Date_Email_2009.html"
target=_blank><FONT face="Arial, Helvetica, sans-serif"
color=#ffffff size=2>View this message in a browser</font></A></DIV></TD></TR>
<TR>
<TD align=middle colSpan=2>
<DIV align=center>
<P><img height=70 alt="Hold the date... 2-3 April "
src="http://www.biotrinity.com/2009/images/banner.gif" width=550></P>
<P><img height=267
alt="The UK's premier biotechnology and investment conference, where great minds and smart money meet under one roof"
src="http://www.biotrinity.com/2009/images/main_image.jpg"
width=550></P></DIV></TD></TR>
<TR>
<TD align=middle width=327
background=http://www.biotrinity.com/2009/images/calloutBG.gif
bgColor=#1e5678><img height=15
src="http://www.biotrinity.com/2009/images/box_top.gif" width=327>
<P class=callout align=left><FONT face="Arial, Helvetica, sans-serif"
color=#ffffff size=2>Now in its 3rd year, OBN’s <STRONG>BioTrinity
2009</STRONG> conference unites the UK’s life science industry. Come and
experience what will be the <STRONG>best biotech partnering and investment
conference</STRONG> in the country through this two-day programme. Join
top-notch industry executives, including the South East region’s most
innovative biotech entrepreneurs, major pharmaceutical companies, life
science research leaders, policy makers and internationally prominent
investors at the biotechnology event of the year: <STRONG>BioTrinity
2009</STRONG>.</FONT></P>
<P class=style2 align=left><STRONG><FONT
face="Arial, Helvetica, sans-serif" color=#ffff00 size=3>  New for
2009:</FONT></STRONG></P>
<DIV align=left>
<UL>
<LI class=callout><FONT face="Arial, Helvetica, sans-serif"
color=#ffffff size=2>Invitation only Investor Dinner</FONT>
<LI class=callout><FONT face="Arial, Helvetica, sans-serif"
color=#ffffff size=2>Biotech Industry Golf Tournament<BR>and Biotech
Community Gala Dinner</FONT>
<LI class=callout><FONT face="Arial, Helvetica, sans-serif"
color=#ffffff size=2>Investment/corporate presentations<BR>by biotech
and life science companies</FONT>
<LI class=callout><FONT face="Arial, Helvetica, sans-serif"
color=#ffffff size=2>Dedicated investment and partnering booths</FONT>
<LI class=callout><FONT face="Arial, Helvetica, sans-serif"
color=#ffffff size=2>Expanded networking space</FONT> </LI></UL>
<P class=style2><FONT face="Arial, Helvetica, sans-serif" color=#ffff00
size=3>  Facts from 2008:</FONT></P>
<UL>
<LI class=callout><FONT face="Arial, Helvetica, sans-serif"
color=#ffffff size=2>500+ one-to-one partnering meetings</FONT>
<LI class=callout><FONT face="Arial, Helvetica, sans-serif"
color=#ffffff size=2>400+ delegates</FONT>
<LI class=callout><FONT face="Arial, Helvetica, sans-serif"
color=#ffffff size=2>270 companies</FONT>
<LI class=callout><FONT face="Arial, Helvetica, sans-serif"
color=#ffffff size=2>12 countries represented</FONT> </LI></UL><img
height=15 alt=box
src="http://www.biotrinity.com/2009/images/box_bottom.gif" width=327
border=0> </DIV></TD>
<TD align=middle width=224>
<P> </P>
<P class=style2><FONT face="Arial, Helvetica, sans-serif" color=#ffff00
size=3>Early Confirmations:</FONT></P>
<P class=style8><FONT face="Arial, Helvetica, sans-serif" color=#ffffff
size=2>  Merck</FONT></P>
<P class=style8><FONT face="Arial, Helvetica, sans-serif" color=#ffffff
size=2>  Brisol Myers-Squibb</FONT></P>
<P class=style8><FONT face="Arial, Helvetica, sans-serif" color=#ffffff
size=2>  Takeda Research Investment Inc</FONT></P>
<P class=style8><FONT face="Arial, Helvetica, sans-serif" color=#ffffff
size=2>  Novo Ventures</FONT></P>
<P class=style8><FONT face="Arial, Helvetica, sans-serif" color=#ffffff
size=2>  Innovator Capital</FONT></P>
<P class=style8><FONT face="Arial, Helvetica, sans-serif" color=#ffffff
size=2>  MP Healthcare Venture Management</FONT></P>
<P class=style8><FONT face="Arial, Helvetica, sans-serif" color=#ffffff
size=2>  Domainex</FONT></P>
<P class=style8><FONT face="Arial, Helvetica, sans-serif" color=#ffffff
size=2>  Cytox Group</FONT></P>
<P class=style8><FONT face="Arial, Helvetica, sans-serif" color=#ffffff
size=2>  Hybrid Systems</FONT></P>
<P class=style8><FONT face="Arial, Helvetica, sans-serif" color=#ffffff
size=2>  Piramed Pharma</FONT></P>
<P class=style7> </P>
<P> </P>
<P><img height=81 alt="BioTrinity logo"
src="http://www.biotrinity.com/2009/images/biotrinity.gif" width=200
align=baseline></P></TD></TR>
<TR>
<TD align=middle bgColor=#020a27 colSpan=2> </TD></TR>
<TR>
<TD align=middle bgColor=#ffffff colSpan=2>
<DIV align=left>
<H1 class=style4> </H1>
<H1 class=style6><FONT face="Arial, Helvetica, sans-serif" color=#020a27
size=5>  WHO SHOULD ATTEND?</FONT></H1>
<H2 class=style5><FONT face="Arial, Helvetica, sans-serif" color=#020a27
size=3>  Biotech & MedTech Executives</FONT></H2>
<UL>
<LI class=mainlist><FONT face="Arial, Helvetica, sans-serif"
color=#020a27 size=2>8 minute presentation opportunity to pharma and
investor audience</FONT>
<LI class=mainlist><FONT face="Arial, Helvetica, sans-serif"
color=#020a27 size=2>Panel discussions for emerging biotechs on finance
and key issues</FONT>
<LI class=mainlist><FONT face="Arial, Helvetica, sans-serif"
color=#020a27 size=2>Private 1-to-1 partnering rooms and booths</FONT>
</LI></UL>
<H2 class=style5><FONT face="Arial, Helvetica, sans-serif" color=#020a27
size=3>  Mid & Large Pharma Executives</FONT></H2>
<UL>
<LI class=mainlist><FONT face="Arial, Helvetica, sans-serif"
color=#020a27 size=2>Access to Company presentations (Biotechnology and
MedTech)</FONT>
<LI class=mainlist><FONT face="Arial, Helvetica, sans-serif"
color=#020a27 size=2>Private 1-to-1 partnering rooms and booths</FONT>
<LI class=mainlist><FONT face="Arial, Helvetica, sans-serif"
color=#020a27 size=2>Opportunity for dedicated partnering rooms</FONT>
</LI></UL>
<H2 class=style5><FONT face="Arial, Helvetica, sans-serif" color=#020a27
size=3>  Investors</FONT></H2>
<UL>
<LI class=mainlist><FONT face="Arial, Helvetica, sans-serif"
color=#020a27 size=2>Invitation-only investor dinner</FONT>
<LI class=mainlist><FONT face="Arial, Helvetica, sans-serif"
color=#020a27 size=2>Wide range of investment opportunities</FONT>
<LI class=mainlist><FONT face="Arial, Helvetica, sans-serif"
color=#020a27 size=2>Private 1-to-1 partnering rooms</FONT>
<LI class=mainlist><FONT face="Arial, Helvetica, sans-serif"
color=#020a27 size=2>Opportunity for dedicated partnering rooms</FONT>
</LI></UL>
<P> </P></DIV></TD></TR>
<TR>
<TD align=left bgColor=#ffffff colSpan=2>
<H1 class=style6><FONT face="Arial, Helvetica, sans-serif" color=#020a27
size=5>  Registration Fees</FONT></H1>
<P class=bluecopy align=left><FONT face="Arial, Helvetica, sans-serif"
color=#020a27 size=2>  Register now online at <A
href="http://www.biotrinity.com">www.biotrinity.com</A> to take advantage
of the Super Early Bird offer</P></FONT>
<P class=bluecopy align=left> </P></TD></TR>
<TR>
<TD class=mainlist align=middle bgColor=#ffffff>
<P class=bluecopy align=left><FONT face="Arial, Helvetica, sans-serif"
color=#020a27 size=2>  Super Early Registration Fee (until Oct 1,
2008)</FONT></P>
<P class=bluecopy align=left><FONT face="Arial, Helvetica, sans-serif"
color=#020a27 size=2>  Early Bird Registration Fee (until Dec 15,
2008)</FONT></P>
<P class=bluecopy align=left><FONT face="Arial, Helvetica, sans-serif"
color=#020a27 size=2>  Special Registration Fee (until Feb 14,
2009)</FONT></P>
<P class=bluecopy align=left><FONT face="Arial, Helvetica, sans-serif"
color=#020a27 size=2>  Registration Fee (until April 1, 2009)</FONT></P>
<P class=bluecopy align=left><FONT face="Arial, Helvetica, sans-serif"
color=#020a27 size=2>  On-site Registration Fee</FONT></P></TD>
<TD class=mainlist align=middle bgColor=#ffffff>
<P class=bluecopy align=left><FONT face="Arial, Helvetica, sans-serif"
color=#020a27 size=2>£449 + VAT</FONT></P>
<P class=bluecopy align=left><FONT face="Arial, Helvetica, sans-serif"
color=#020a27 size=2>£499 + VAT</FONT></P>
<P class=bluecopy align=left><FONT face="Arial, Helvetica, sans-serif"
color=#020a27 size=2>£549 + VAT</FONT></P>
<P class=bluecopy align=left><FONT face="Arial, Helvetica, sans-serif"
color=#020a27 size=2>£599 + VAT</FONT></P>
<P class=bluecopy align=left><FONT face="Arial, Helvetica, sans-serif"
color=#020a27 size=2>£650 + VAT</FONT></P></TD></TR>
<TR>
<TD align=middle bgColor=#ffffff colSpan=2>
<P> </P>
<P align=center><A href="http://www.biotrinity.com"><img height=95
alt=BioTrinity.com
src="http://www.biotrinity.com/2009/images/biotrinitylink.gif" width=204
border=0></A></P>
<P> </P></TD></TR></TBODY></TABLE>
<!-- begin subscription_form_widget.tmpl -->
<form action="http://www.biotrinity.com/cgi-bin/dada/mail.cgi" method="post">
<fieldset>
<legend>
Subscribe/Unsubscribe on BioTrinity - Keep me informed
</legend>
<input type="hidden" name="list" value="premarketing" />
<p>
<label for="email" style="width: 7em;float: left;text-align: right;margin-right: 0.5em;display: block" >
Email Address:
</label>
<input type="text" name="email" id="email" value="" /> <span class="error">* Required</span>
</p>
<hr style="border-top: 1px solid black;" />
<p>
<label for="f_s" style="width: 7em;float: left;text-align: right;margin-right: 0.5em;display: block">
Subscribe
</label>
<input type="radio" name="f" id="f_s" value="subscribe" checked="checked" />
</p>
<p>
<label for="f_u" style="width: 7em;float: left;text-align: right;margin-right: 0.5em;display: block">Unsubscribe</label>
<input type="radio" name="f" id="f_u" value="unsubscribe" />
</p>
<hr style="border-top: 1px solid black;" />
<p style="text-align:right;display:block">
<input type="submit" value="Submit Your Information" class="processing" />
</p>
</fieldset>
</form>
<!-- end subscription_form_widget.tmpl -->
Hold the Date for BioTrinity 2009: UK's Premier Biotechnology and Investment conference - early registration opens
tag:www.biotrinity.com,2008-09-04:%2Fcgi-bin%2Fdada%2Fmail.cgi%2Farchive%2Fpremarketing%2F20080904093643%2F
2008-09-04T09:36:43Z
2008-09-04T09:36:43Z
<TABLE cellSpacing=0 cellPadding=0 width=550 align=center bgColor=#020a27>
<TBODY>
<TR>
<TD height=25 ALIGN="middle" COLSPAN=2>
<DIV align=center><A href="http://www.biotrinity.com/2009/BioTrinity_Hold_the_Date_Email_2009.html"
target=_blank><FONT face="Arial, Helvetica, sans-serif"
color=#ffffff size=2>View this message in a browser</font></A></DIV></TD></TR>
<TR>
<TD align=middle colSpan=2>
<DIV align=center>
<P><img height=70 alt="Hold the date... 2-3 April "
src="http://www.biotrinity.com/2009/images/banner.gif" width=550></P>
<P><img height=267
alt="The UK's premier biotechnology and investment conference, where great minds and smart money meet under one roof"
src="http://www.biotrinity.com/2009/images/main_image.jpg"
width=550></P></DIV></TD></TR>
<TR>
<TD align=middle width=327
background=http://www.biotrinity.com/2009/images/calloutBG.gif
bgColor=#1e5678><img height=15
src="http://www.biotrinity.com/2009/images/box_top.gif" width=327>
<P class=callout align=left><FONT face="Arial, Helvetica, sans-serif"
color=#ffffff size=2>Now in its 3rd year, OBN’s <STRONG>BioTrinity
2009</STRONG> conference unites the UK’s life science industry. Come and
experience what will be the <STRONG>best biotech partnering and investment
conference</STRONG> in the country through this two-day programme. Join
top-notch industry executives, including the South East region’s most
innovative biotech entrepreneurs, major pharmaceutical companies, life
science research leaders, policy makers and internationally prominent
investors at the biotechnology event of the year: <STRONG>BioTrinity
2009</STRONG>.</FONT></P>
<P class=style2 align=left><STRONG><FONT
face="Arial, Helvetica, sans-serif" color=#ffff00 size=3>  New for
2009:</FONT></STRONG></P>
<DIV align=left>
<UL>
<LI class=callout><FONT face="Arial, Helvetica, sans-serif"
color=#ffffff size=2>Invitation only Investor Dinner</FONT>
<LI class=callout><FONT face="Arial, Helvetica, sans-serif"
color=#ffffff size=2>Biotech Industry Golf Tournament<BR>and Biotech
Community Gala Dinner</FONT>
<LI class=callout><FONT face="Arial, Helvetica, sans-serif"
color=#ffffff size=2>Investment/corporate presentations<BR>by biotech
and life science companies</FONT>
<LI class=callout><FONT face="Arial, Helvetica, sans-serif"
color=#ffffff size=2>Dedicated investment and partnering booths</FONT>
<LI class=callout><FONT face="Arial, Helvetica, sans-serif"
color=#ffffff size=2>Expanded networking space</FONT> </LI></UL>
<P class=style2><FONT face="Arial, Helvetica, sans-serif" color=#ffff00
size=3>  Facts from 2008:</FONT></P>
<UL>
<LI class=callout><FONT face="Arial, Helvetica, sans-serif"
color=#ffffff size=2>500+ one-to-one partnering meetings</FONT>
<LI class=callout><FONT face="Arial, Helvetica, sans-serif"
color=#ffffff size=2>400+ delegates</FONT>
<LI class=callout><FONT face="Arial, Helvetica, sans-serif"
color=#ffffff size=2>270 companies</FONT>
<LI class=callout><FONT face="Arial, Helvetica, sans-serif"
color=#ffffff size=2>12 countries represented</FONT> </LI></UL><img
height=15 alt=box
src="http://www.biotrinity.com/2009/images/box_bottom.gif" width=327
border=0> </DIV></TD>
<TD align=middle width=224>
<P> </P>
<P class=style2><FONT face="Arial, Helvetica, sans-serif" color=#ffff00
size=3>Early Confirmations:</FONT></P>
<P class=style8><FONT face="Arial, Helvetica, sans-serif" color=#ffffff
size=2>  Merck</FONT></P>
<P class=style8><FONT face="Arial, Helvetica, sans-serif" color=#ffffff
size=2>  Brisol Myers-Squibb</FONT></P>
<P class=style8><FONT face="Arial, Helvetica, sans-serif" color=#ffffff
size=2>  Takeda Research Investment Inc</FONT></P>
<P class=style8><FONT face="Arial, Helvetica, sans-serif" color=#ffffff
size=2>  Novo Ventures</FONT></P>
<P class=style8><FONT face="Arial, Helvetica, sans-serif" color=#ffffff
size=2>  Innovator Capital</FONT></P>
<P class=style8><FONT face="Arial, Helvetica, sans-serif" color=#ffffff
size=2>  MP Healthcare Venture Management</FONT></P>
<P class=style8><FONT face="Arial, Helvetica, sans-serif" color=#ffffff
size=2>  Domainex</FONT></P>
<P class=style8><FONT face="Arial, Helvetica, sans-serif" color=#ffffff
size=2>  Cytox Group</FONT></P>
<P class=style8><FONT face="Arial, Helvetica, sans-serif" color=#ffffff
size=2>  Hybrid Systems</FONT></P>
<P class=style8><FONT face="Arial, Helvetica, sans-serif" color=#ffffff
size=2>  Piramed Pharma</FONT></P>
<P class=style7> </P>
<P> </P>
<P><img height=81 alt="BioTrinity logo"
src="http://www.biotrinity.com/2009/images/biotrinity.gif" width=200
align=baseline></P></TD></TR>
<TR>
<TD align=middle bgColor=#020a27 colSpan=2> </TD></TR>
<TR>
<TD align=middle bgColor=#ffffff colSpan=2>
<DIV align=left>
<H1 class=style4> </H1>
<H1 class=style6><FONT face="Arial, Helvetica, sans-serif" color=#020a27
size=5>  WHO SHOULD ATTEND?</FONT></H1>
<H2 class=style5><FONT face="Arial, Helvetica, sans-serif" color=#020a27
size=3>  Biotech & MedTech Executives</FONT></H2>
<UL>
<LI class=mainlist><FONT face="Arial, Helvetica, sans-serif"
color=#020a27 size=2>8 minute presentation opportunity to pharma and
investor audience</FONT>
<LI class=mainlist><FONT face="Arial, Helvetica, sans-serif"
color=#020a27 size=2>Panel discussions for emerging biotechs on finance
and key issues</FONT>
<LI class=mainlist><FONT face="Arial, Helvetica, sans-serif"
color=#020a27 size=2>Private 1-to-1 partnering rooms and booths</FONT>
</LI></UL>
<H2 class=style5><FONT face="Arial, Helvetica, sans-serif" color=#020a27
size=3>  Mid & Large Pharma Executives</FONT></H2>
<UL>
<LI class=mainlist><FONT face="Arial, Helvetica, sans-serif"
color=#020a27 size=2>Access to Company presentations (Biotechnology and
MedTech)</FONT>
<LI class=mainlist><FONT face="Arial, Helvetica, sans-serif"
color=#020a27 size=2>Private 1-to-1 partnering rooms and booths</FONT>
<LI class=mainlist><FONT face="Arial, Helvetica, sans-serif"
color=#020a27 size=2>Opportunity for dedicated partnering rooms</FONT>
</LI></UL>
<H2 class=style5><FONT face="Arial, Helvetica, sans-serif" color=#020a27
size=3>  Investors</FONT></H2>
<UL>
<LI class=mainlist><FONT face="Arial, Helvetica, sans-serif"
color=#020a27 size=2>Invitation-only investor dinner</FONT>
<LI class=mainlist><FONT face="Arial, Helvetica, sans-serif"
color=#020a27 size=2>Wide range of investment opportunities</FONT>
<LI class=mainlist><FONT face="Arial, Helvetica, sans-serif"
color=#020a27 size=2>Private 1-to-1 partnering rooms</FONT>
<LI class=mainlist><FONT face="Arial, Helvetica, sans-serif"
color=#020a27 size=2>Opportunity for dedicated partnering rooms</FONT>
</LI></UL>
<P> </P></DIV></TD></TR>
<TR>
<TD align=left bgColor=#ffffff colSpan=2>
<H1 class=style6><FONT face="Arial, Helvetica, sans-serif" color=#020a27
size=5>  Registration Fees</FONT></H1>
<P class=bluecopy align=left><FONT face="Arial, Helvetica, sans-serif"
color=#020a27 size=2>  Register now online at <A
href="http://www.biotrinity.com">www.biotrinity.com</A> to take advantage
of the Super Early Bird offer</P></FONT>
<P class=bluecopy align=left> </P></TD></TR>
<TR>
<TD class=mainlist align=middle bgColor=#ffffff>
<P class=bluecopy align=left><FONT face="Arial, Helvetica, sans-serif"
color=#020a27 size=2>  Super Early Registration Fee (until Oct 1,
2008)</FONT></P>
<P class=bluecopy align=left><FONT face="Arial, Helvetica, sans-serif"
color=#020a27 size=2>  Early Bird Registration Fee (until Dec 15,
2008)</FONT></P>
<P class=bluecopy align=left><FONT face="Arial, Helvetica, sans-serif"
color=#020a27 size=2>  Special Registration Fee (until Feb 14,
2009)</FONT></P>
<P class=bluecopy align=left><FONT face="Arial, Helvetica, sans-serif"
color=#020a27 size=2>  Registration Fee (until April 1, 2009)</FONT></P>
<P class=bluecopy align=left><FONT face="Arial, Helvetica, sans-serif"
color=#020a27 size=2>  On-site Registration Fee</FONT></P></TD>
<TD class=mainlist align=middle bgColor=#ffffff>
<P class=bluecopy align=left><FONT face="Arial, Helvetica, sans-serif"
color=#020a27 size=2>£449 + VAT</FONT></P>
<P class=bluecopy align=left><FONT face="Arial, Helvetica, sans-serif"
color=#020a27 size=2>£499 + VAT</FONT></P>
<P class=bluecopy align=left><FONT face="Arial, Helvetica, sans-serif"
color=#020a27 size=2>£549 + VAT</FONT></P>
<P class=bluecopy align=left><FONT face="Arial, Helvetica, sans-serif"
color=#020a27 size=2>£599 + VAT</FONT></P>
<P class=bluecopy align=left><FONT face="Arial, Helvetica, sans-serif"
color=#020a27 size=2>£650 + VAT</FONT></P></TD></TR>
<TR>
<TD align=middle bgColor=#ffffff colSpan=2>
<P> </P>
<P align=center><A href="http://www.biotrinity.com"><img height=95
alt=BioTrinity.com
src="http://www.biotrinity.com/2009/images/biotrinitylink.gif" width=204
border=0></A></P>
<P> </P></TD></TR></TBODY></TABLE>
<!-- begin subscription_form_widget.tmpl -->
<form action="http://www.biotrinity.com/cgi-bin/dada/mail.cgi" method="post">
<fieldset>
<legend>
Subscribe/Unsubscribe on BioTrinity - Keep me informed
</legend>
<input type="hidden" name="list" value="premarketing" />
<p>
<label for="email" style="width: 7em;float: left;text-align: right;margin-right: 0.5em;display: block" >
Email Address:
</label>
<input type="text" name="email" id="email" value="" /> <span class="error">* Required</span>
</p>
<hr style="border-top: 1px solid black;" />
<p>
<label for="f_s" style="width: 7em;float: left;text-align: right;margin-right: 0.5em;display: block">
Subscribe
</label>
<input type="radio" name="f" id="f_s" value="subscribe" checked="checked" />
</p>
<p>
<label for="f_u" style="width: 7em;float: left;text-align: right;margin-right: 0.5em;display: block">Unsubscribe</label>
<input type="radio" name="f" id="f_u" value="unsubscribe" />
</p>
<hr style="border-top: 1px solid black;" />
<p style="text-align:right;display:block">
<input type="submit" value="Submit Your Information" class="processing" />
</p>
</fieldset>
</form>
<!-- end subscription_form_widget.tmpl -->
Last minute exhibition stand space available at BioTrinity 2008
tag:www.biotrinity.com,2008-04-11:%2Fcgi-bin%2Fdada%2Fmail.cgi%2Farchive%2Fpremarketing%2F20080411152100%2F
2008-04-11T15:21:00Z
2008-04-11T15:21:00Z
<TABLE
style="PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: 0px; WIDTH: 100%; PADDING-TOP: 0px; HEIGHT: 100%; BACKGROUND-COLOR: #002a3b">
<TBODY>
<TR>
<TD bgColor=#002a3b>
<TABLE borderColor=#ffffff cellSpacing=0 cellPadding=0 width=600
align=center bgColor=#ffffff border=0>
<TBODY>
<TR>
<TD bgColor=#002a3b><SPAN style="BACKGROUND-COLOR: #002a3b"><A
href="http://www.biotrinity.com" target=_blank></A></SPAN><BR></TD></TR>
<TR>
<TD>
<DIV align=center><A
href="http://www.biotrinity.com/registration.html"><IMG
src="http://biotrinity.com/images/email_logo.gif" border=0>
</A></DIV></TD></TR>
<TR>
<TD style="PADDING-LEFT: 5px; PADDING-BOTTOM: 10px" vAlign=top
rowSpan=2>
<P class=MsoNormal><B><FONT face=Arial color=#003366 size=2><SPAN
style="FONT-WEIGHT: bold; FONT-SIZE: 10pt; COLOR: #003366; FONT-FAMILY: Arial"><o:p></o:p></SPAN></FONT></B> </P>
<DIV align=center><IMG
src="http://biotrinity.com/email/negative_photo_strip.jpg"
border=0></DIV>
<P
style="PADDING-LEFT: 10px; FONT-SIZE: 1.2em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left>BioTrinity 2008 - Oxford, April 15-16, 2008
<P
style="PADDING-RIGHT: 10px; FONT-SIZE: 1.2em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=right>Exhibition Stand space available at BioTrinity - ring
01865 594642<STRONG><U></U></STRONG>
<P
style="FONT-SIZE: 0.9em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left>We'd like to inform you that a single 2x2m exhibition
stand space has just become available at BioTrinity 2008, please
contact the OBN office on 01865 594642 or call Jon Rees on 07795
233883 if you want to reserve this - first come first served. Demand
is such that we expect this to be sold within 2 hours.</P>
<P
style="FONT-SIZE: 0.9em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=center><FONT face="Trebuchet MS"><EM>Partnering is live!</EM>
<A style="COLOR: #025273"
href="http://www.biotrinity.com/registration.html">Register online
now</A> </FONT></SPAN></FONT></B></P></SPAN><SPAN class=style3>
<TABLE>
<TBODY>
<TR>
<TD width=100></TD>
<TD>
<P
style="FONT-SIZE: 0.9em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left><IMG
src="http://www.biotrinity.com/images/tri.gif">Over
<STRONG>370</STRONG> delegates already confirmed<BR><IMG
src="http://www.biotrinity.com/images/tri.gif"><STRONG>245</STRONG> <A
href="http://www.biotrinity.com/companies_attending.html">companies</A>
already confirmed<BR><IMG
src="http://www.biotrinity.com/images/tri.gif"><STRONG>1800</STRONG> partnering
requests already made<BR><IMG
src="http://www.biotrinity.com/images/tri.gif">Over
<STRONG>100</STRONG> licensing
opportunities available </P></TD></TR></TBODY></TABLE></SPAN>
<P></P>
<H3
style="FONT-SIZE: small; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left><STRONG>
<P
style="PADDING-RIGHT: 0px; FONT-SIZE: 0.7em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=center>...........................................................................................</P></STRONG></H3>
<H3
style="FONT-SIZE: small; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left><STRONG>BioTrinity 2008 - Oxford: Logged in to the
partnering system recently?</STRONG></H3>
<P
style="PADDING-RIGHT: 0px; FONT-SIZE: 0.8em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left>BioTrinity has seen veritable blitz of activity from
delegates over recent days with 1800 meeting requests already
in the one-to-one partnering system, over 100 licensing
opportunities, and we now expect over 375 delegates from over 250
companies, from 12 countries to attend BioTrinity next week 15-16th
April 2008. It's not too late to register, online registration will
close 5 PM GMT Friday 11th April, contact the OBN office on +44
(0)1865 594640 or <A
href="mailto:info@oxfordshirebioscience.net">info@oxfordshirebioscience.net</A> to
register after this time.</P>
<P
style="PADDING-RIGHT: 0px; FONT-SIZE: 0.8em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left>If you have not used the partnering system yet - please
consider logging in over the weekend to start making and accepting
meeting requests from other delegates which may be waiting for you
to respond.</P>
<P
style="PADDING-RIGHT: 0px; FONT-SIZE: 0.8em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left>The BioTrinity 2008 programme has changed
<EM>signficantly</EM> since we first advertised, so if you are not
aware of our significant improvements to the conference programme,
please take a look at the latest programme summary - see <A
href="http://www.tinyurl.com/453983">http://www.tinyurl.com/453983</A></P>
<P
style="PADDING-RIGHT: 0px; FONT-SIZE: 0.8em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left>To whet your appetite for partnering here's a list of ten
very recent registrations: <STRONG>Antisoma, Cyprotex, BioFocus DPI,
L&K Biosciences (Denmark), Ono Pharma, LFI, NYSE Euronext (USA),
RUSSLAN Clinical Research, Systems Biology Laboratory, Technomark
Life Sciences (USA)</STRONG>. </P>
<P
style="PADDING-RIGHT: 0px; FONT-SIZE: 0.8em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left>To view the full list of companies already confirmed as
participating, see: <A
href="http://www.biotrinity.com/companies_attending.html">http://www.biotrinity.com/companies_attending.html</A></P>
<P
style="PADDING-RIGHT: 0px; FONT-SIZE: 0.8em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left>Register before 5PM this Friday to get it all done online
and start requesting one-to-one meetings! </P>
<P
style="PADDING-RIGHT: 0px; FONT-SIZE: 0.8em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left>To Register go online to <A
href="http://www.biotrinity.com">www.biotrinity.com</A> or call +44
(0)1865 594640</P>
<P
style="PADDING-RIGHT: 0px; FONT-SIZE: 0.7em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=center>...........................................................................................</P>
<H3
style="FONT-SIZE: small; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left><STRONG>What other people think: </STRONG></H3>
<P
style="FONT-SIZE: 0.7em; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left><EM>"...I would like to congratulate you on an excellent
meeting.."</EM><BR>Tim Haines, Partner, <STRONG>Abingworth
Management</STRONG>
<P
style="FONT-SIZE: 0.7em; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left><EM>"...Congratulations on such a good event. I had a
very productive day with lots of organized and impromptu meetings -
a very worthwhile event for me." </EM>Dr Charles Potter, CEO,
<STRONG>Glide Pharma</STRONG>
<P
style="FONT-SIZE: 0.7em; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left>"<EM>I am delighted to be speaking at BioTrinity 2008,
which is an opportune platform on which we can discuss the recent
milestones achieved in the development of TroVax, our lead cancer
immunotherapy</EM>." Peter Nolan, SVP Commercial Development at
<STRONG>Oxford BioMedica</STRONG><BR>
<P
style="PADDING-RIGHT: 10px; FONT-SIZE: 0.7em; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=right><A
href="http://www.biotrinity.com/testimonials.html">Read
testimonials...</A><BR>
<P
style="PADDING-RIGHT: 0px; FONT-SIZE: 0.7em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=center>...........................................................................................</P>
<P
style="FONT-SIZE: 0.7em; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left>Register now and start partnering:<A
href="http://www.biotrinity.com/">www.biotrinity.com</A>
<P
style="PADDING-RIGHT: 0px; FONT-SIZE: 0.7em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left><A
href="http://www.partneringgate.com/registration.php?id=3244f$b7trFN6q5zTQo&regtype=7344f$b7e9fTFw2a6rc"><IMG
height=88 alt="Register online now! www.biotrinity.com"
src="http://www.biotrinity.com/email/2008/register2.jpg" width=205
border=0></A>
<P
style="PADDING-RIGHT: 0px; FONT-SIZE: 0.7em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=center>............................................................................................</P>
<H4
style="COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left>Contact details:</H4>
<P
style="FONT-SIZE: 0.7em; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left>Jon Rees, Network Director, OBN <BR>Suite L, Park House
<BR>11 Milton Park, Abingdon<BR>Oxfordshire OX14 4RA<BR>Tel. +44 (0)
1865 594640<BR>Fax. +44 (0) 1235 835843<BR><A style="COLOR: #025273"
href="mailto:jon.rees@oxfordshirebioscience.net">jon.rees@oxfordshirebioscience.net</A></P><BR>
<P
style="PADDING-RIGHT: 0px; FONT-SIZE: 0.9em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=center>Register online now at <A
href="http://www.biotrinity.com/">www.biotrinity.com</A></P>
<P
style="FONT-SIZE: 0.7em; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left> </P>
<P
style="PADDING-RIGHT: 0px; FONT-SIZE: 0.7em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left>............................................................................................</P>
<H5
style="PADDING-LEFT: 5px; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left>BioTrinity sponsors</H5>
<P align=center><IMG height=63 alt=Stimutran
src="http://www.biotrinity.com/email/2008/sponsors/stimutran.gif"
width=100 border=0> </P>
<P align=center><IMG height=63 alt="Milton Park"
src="http://www.biotrinity.com/email/2008/sponsors/milton.gif"
width=100 border=0> 
<P align=center><IMG height=63 alt="UK Trade & Investment"
src="http://www.biotrinity.com/email/2008/sponsors/UKTI.gif"
width=100 border=0> <IMG height=63
alt="Merck Sharpe Dohme"
src="http://www.biotrinity.com/email/2008/sponsors/msd.gif"
width=100 border=0>  <IMG height=63 alt=genzyme
src="http://www.biotrinity.com/email/2008/sponsors/genzyme.gif"
width=100 border=0></P>
<P align=center> <IMG height=63 alt="Grant Thornton"
src="http://www.biotrinity.com/email/2008/sponsors/GT.gif" width=100
border=0> <IMG height=63 alt="Helvoet Pharma"
src="http://www.biotrinity.com/email/2008/sponsors/helvoet.gif"
width=100 border=0>   <IMG height=63 alt=SEHTA
src="http://www.biotrinity.com/email/2008/sponsors/sehta.gif"
width=100 border=0>
<P align=center>  <IMG height=63 alt="Thermo Fisher"
src="http://www.biotrinity.com/email/2008/sponsors/fisher.gif"
width=100 border=0>  <IMG height=63 alt=Thomson
src="http://www.biotrinity.com/email/2008/sponsors/thomson.gif"
width=100 border=0>  <IMG height=63 alt="De Facto"
src="http://www.biotrinity.com/email/2008/sponsors/defacto.gif"
width=100 border=0> </P>
<P align=center> <IMG height=63 alt=Manches
src="http://www.biotrinity.com/email/2008/sponsors/manches.gif"
width=100 border=0> <IMG height=63 alt=RDP
src="http://www.biotrinity.com/email/2008/sponsors/RDP.gif"
width=100 border=0> <IMG height=63
alt="Giles Insurance Brokers"
src="http://www.biotrinity.com/email/2008/sponsors/giles_100x63.jpg"
width=100 border=0>
<P align=center> <IMG height=63
alt="Biotechnology Finance Advisory Service"
src="http://www.biotrinity.com/email/2008/sponsors/BFAS_logo.gif"
width=100 border=0> <IMG height=63 alt="Pharma Ventures"
src="http://www.biotrinity.com/email/2008/sponsors/PharmaVcolour.gif"
width=100 border=0> </P>
<P
style="PADDING-RIGHT: 0px; FONT-SIZE: 0.7em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left>............................................................................................</P>
<H5
style="PADDING-LEFT: 5px; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left>BioTrinity partners</H5>
<P align=center><IMG height=63 alt=BioSpectrum
src="http://www.biotrinity.com/email/2008/partners/biospectrum.gif"
width=100 border=0> <IMG height=63
alt="Drug Discovery Today"
src="http://www.biotrinity.com/email/2008/partners/ddt.gif"
width=100 border=0>   <IMG height=63 alt=LBN
src="http://www.biotrinity.com/images/network_logos/lbn.jpg"
width=100 border=0>  </P>
<P align=center><IMG height=63 alt="European Biotechnology News"
src="http://www.biotrinity.com/email/2008/partners/EBN.gif"
width=100 border=0> <IMG height=63 alt=TVLSN
src="http://www.biotrinity.com/email/2008/partners/tvlsn.jpg"
width=100 border=0>  <IMG height=63 alt=BioProcessUK
src="http://www.biotrinity.com/email/2008/partners/bioprocessuk.gif"
width=100 border=0> </P>
<P align=center><IMG height=63 alt=Pharmalicensing
src="http://www.biotrinity.com/email/2008/partners/pharmalicensing.gif"
width=100 border=0>    <IMG height=63 alt=MedNous
src="http://www.biotrinity.com/images/mednous.jpg" width=100
border=0> </P>
<P
style="PADDING-RIGHT: 0px; FONT-SIZE: 0.7em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left>............................................................................................</P>
<H5
style="PADDING-LEFT: 5px; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left>BioTrinity is organised by OBN</H5>
<P align=center><A href="http://www.oxfordshirebioscience.com"><IMG
height=63 alt=OBN
src="http://www.biotrinity.com/email/2008/sponsors/obn_100x63.gif"
width=100 border=0></A> </P>
<P></P>
<P align=center> </P></TD></TR>
<TR></TR>
<TR>
<TD bgColor=#025273>
<P
style="FONT-SIZE: x-small; COLOR: #fff; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial,
sans-serif"
align=center>© 2006-2008 <A style="COLOR: #fff"
href="http://www.oxfordshirebioscience.com">OBN</A></P>
<P></P></TD></TR></TBODY></TABLE></TD></TR></TBODY></TABLE>
<!-- begin subscription_form_widget.tmpl -->
<form action="http://www.biotrinity.com/cgi-bin/dada/mail.cgi" method="post">
<fieldset>
<legend>
Subscribe/Unsubscribe on BioTrinity - Keep me informed
</legend>
<input type="hidden" name="list" value="premarketing" />
<p>
<label for="email" style="width: 7em;float: left;text-align: right;margin-right: 0.5em;display: block" >
Email Address:
</label>
<input type="text" name="email" id="email" value="" /> <span class="error">* Required</span>
</p>
<hr style="border-top: 1px solid black;" />
<p>
<label for="f_s" style="width: 7em;float: left;text-align: right;margin-right: 0.5em;display: block">
Subscribe
</label>
<input type="radio" name="f" id="f_s" value="subscribe" checked="checked" />
</p>
<p>
<label for="f_u" style="width: 7em;float: left;text-align: right;margin-right: 0.5em;display: block">Unsubscribe</label>
<input type="radio" name="f" id="f_u" value="unsubscribe" />
</p>
<hr style="border-top: 1px solid black;" />
<p style="text-align:right;display:block">
<input type="submit" value="Submit Your Information" class="processing" />
</p>
</fieldset>
</form>
<!-- end subscription_form_widget.tmpl -->
BioTrinity 2008 Oxford: 55 hours left to register online - partnering activity surges
tag:www.biotrinity.com,2008-04-09:%2Fcgi-bin%2Fdada%2Fmail.cgi%2Farchive%2Fpremarketing%2F20080409113407%2F
2008-04-09T11:34:07Z
2008-04-09T11:34:07Z
<TABLE
style="PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: 0px; WIDTH: 100%; PADDING-TOP: 0px; HEIGHT: 100%; BACKGROUND-COLOR: #002a3b">
<TBODY>
<TR>
<TD bgColor=#002a3b>
<TABLE borderColor=#ffffff cellSpacing=0 cellPadding=0 width=600
align=center bgColor=#ffffff border=0>
<TBODY>
<TR>
<TD bgColor=#002a3b><SPAN style="BACKGROUND-COLOR: #002a3b"><A
href="http://www.biotrinity.com" target=_blank></A></SPAN><BR></TD></TR>
<TR>
<TD>
<DIV align=center><A
href="http://www.biotrinity.com/registration.html"><IMG
src="http://biotrinity.com/images/email_logo.gif" border=0>
</A></DIV></TD></TR>
<TR>
<TD style="PADDING-LEFT: 5px; PADDING-BOTTOM: 10px" vAlign=top
rowSpan=2>
<P class=MsoNormal><B><FONT face=Arial color=#003366 size=2><SPAN
style="FONT-WEIGHT: bold; FONT-SIZE: 10pt; COLOR: #003366; FONT-FAMILY: Arial"><o:p></o:p></SPAN></FONT></B> </P>
<DIV align=center><IMG
src="http://biotrinity.com/email/negative_photo_strip.jpg"
border=0></DIV>
<P
style="PADDING-LEFT: 10px; FONT-SIZE: 1.2em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left>BioTrinity 2008 - Oxford, April 15-16, 2008
<P
style="PADDING-RIGHT: 10px; FONT-SIZE: 1.2em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=right>55 hours left to register online - <STRONG><U>partnering
activity surges</U></STRONG>
<P
style="FONT-SIZE: 0.9em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left>OBN invites you to participate in BioTrinity, the
South-East England’s equivalent of the ERBI BioExchange. With
just a few days to go before BioTrinity 2008 can you
afford to be missing from the list of <STRONG>240</STRONG>
companies <EM>already</EM> confirmed for April 15-16 in Oxford? </P>
<P
style="FONT-SIZE: 0.9em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=center><FONT face="Trebuchet MS"><EM>Partnering is live!</EM>
<A style="COLOR: #025273"
href="http://www.biotrinity.com/registration.html">Register online
now</A> </FONT></SPAN></FONT></B></P></SPAN><SPAN class=style3>
<TABLE>
<TBODY>
<TR>
<TD width=100></TD>
<TD>
<P
style="FONT-SIZE: 0.9em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left><IMG
src="http://www.biotrinity.com/images/tri.gif"><STRONG>350</STRONG> delegates
already confirmed<BR><IMG
src="http://www.biotrinity.com/images/tri.gif"><STRONG>240</STRONG> <A
href="http://www.biotrinity.com/companies_attending.html">companies</A>
already confirmed<BR><IMG
src="http://www.biotrinity.com/images/tri.gif">Over
<STRONG>1500</STRONG> of partnering requests already
made<BR><IMG
src="http://www.biotrinity.com/images/tri.gif">Over
<STRONG>100</STRONG> licensing opportunities already
available </P></TD></TR></TBODY></TABLE></SPAN>
<P></P>
<H3
style="FONT-SIZE: small; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left><STRONG>
<P
style="PADDING-RIGHT: 0px; FONT-SIZE: 0.7em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=center>...........................................................................................</P></STRONG></H3>
<H3
style="FONT-SIZE: small; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left><STRONG>BioTrinity 2008 - Oxford sees surge of partnering
activity</STRONG></H3>
<P
style="PADDING-RIGHT: 0px; FONT-SIZE: 0.8em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left>BioTrinity has seen veritable blitz of activity from
delegates over recent days with over 1500 meeting requests already
in the one-to-one partnering system, over 100 licensing
opportunities, and we now expect over 375 delegates from over 250
companies, from 12 countries to attend BioTrinity next week 15-16th
April 2008. It's not too late to register, online registration will
close 5 PM GMT Friday 11th April, contact the OBN office on +44
(0)1865 594640 or <A
href="mailto:info@oxfordshirebioscience.net">info@oxfordshirebioscience.net</A> to
register after this time.</P>
<P
style="PADDING-RIGHT: 0px; FONT-SIZE: 0.8em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left>BioTrinity delegates should check the partnering system
today, since we have recently taken steps to make sure all
partnering companies are visible to other delegates. OBN had
received reports that a number of attending companies has mistakenly
set their partnering profiles invisible to other delegates: we have
now addressed this issue. You should now find over 90% of companies
available for one-to-one partnering. If you need help with the
partnering system call 01865 594640.</P>
<P
style="PADDING-RIGHT: 0px; FONT-SIZE: 0.8em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left>The BioTrinity 2008 programme has changed
<EM>signficantly</EM> since we first advertised, so if you are not
aware of our significant improvements to the conference programme,
please take a look at the latest programme summary - see <A
href="http://www.tinyurl.com/453983">http://www.tinyurl.com/453983</A></P>
<P
style="PADDING-RIGHT: 0px; FONT-SIZE: 0.8em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left>To whet your appetite for partnering here's a list of ten
very recent registrations: <STRONG>Antisoma, Cyprotex, BioFocus DPI,
L&K Biosciences (Denmark), Ono Pharma, LFI, NYSE Euronext (USA),
RUSSLAN Clinical Research, Systems Biology Laboratory, Technomark
Life Sciences (USA)</STRONG>. </P>
<P
style="PADDING-RIGHT: 0px; FONT-SIZE: 0.8em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left>To view the full list of companies already confirmed as
participating, see: <A
href="http://www.biotrinity.com/companies_attending.html">http://www.biotrinity.com/companies_attending.html</A></P>
<P
style="PADDING-RIGHT: 0px; FONT-SIZE: 0.8em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left>Register before 5PM this Friday to get it all done online
and start requesting one-to-one meetings! </P>
<P
style="PADDING-RIGHT: 0px; FONT-SIZE: 0.8em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left>To Register go online to <A
href="http://www.biotrinity.com">www.biotrinity.com</A> or call +44
(0)1865 594640</P>
<P
style="PADDING-RIGHT: 0px; FONT-SIZE: 0.7em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=center>...........................................................................................</P>
<H3
style="FONT-SIZE: small; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left><STRONG>What other people think: </STRONG></H3>
<P
style="FONT-SIZE: 0.7em; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left><EM>"...I would like to congratulate you on an excellent
meeting.."</EM><BR>Tim Haines, Partner, <STRONG>Abingworth
Management</STRONG>
<P
style="FONT-SIZE: 0.7em; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left><EM>"...Congratulations on such a good event. I had a
very productive day with lots of organized and impromptu meetings -
a very worthwhile event for me." </EM>Dr Charles Potter, CEO,
<STRONG>Glide Pharma</STRONG>
<P
style="FONT-SIZE: 0.7em; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left>"<EM>I am delighted to be speaking at BioTrinity 2008,
which is an opportune platform on which we can discuss the recent
milestones achieved in the development of TroVax, our lead cancer
immunotherapy</EM>." Peter Nolan, SVP Commercial Development at
<STRONG>Oxford BioMedica</STRONG><BR>
<P
style="PADDING-RIGHT: 10px; FONT-SIZE: 0.7em; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=right><A
href="http://www.biotrinity.com/testimonials.html">Read
testimonials...</A><BR>
<P
style="PADDING-RIGHT: 0px; FONT-SIZE: 0.7em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=center>...........................................................................................</P>
<P
style="FONT-SIZE: 0.7em; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left>Register now and start partnering:<A
href="http://www.biotrinity.com/">www.biotrinity.com</A>
<P
style="PADDING-RIGHT: 0px; FONT-SIZE: 0.7em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left><A
href="http://www.partneringgate.com/registration.php?id=3244f$b7trFN6q5zTQo&regtype=7344f$b7e9fTFw2a6rc"><IMG
height=88 alt="Register online now! www.biotrinity.com"
src="http://www.biotrinity.com/email/2008/register2.jpg" width=205
border=0></A>
<P
style="PADDING-RIGHT: 0px; FONT-SIZE: 0.7em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=center>............................................................................................</P>
<H4
style="COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left>Contact details:</H4>
<P
style="FONT-SIZE: 0.7em; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left>Jon Rees, Network Director, OBN <BR>Suite L, Park House
<BR>11 Milton Park, Abingdon<BR>Oxfordshire OX14 4RA<BR>Tel. +44 (0)
1865 594640<BR>Fax. +44 (0) 1235 835843<BR><A style="COLOR: #025273"
href="mailto:jon.rees@oxfordshirebioscience.net">jon.rees@oxfordshirebioscience.net</A></P><BR>
<P
style="PADDING-RIGHT: 0px; FONT-SIZE: 0.9em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=center>Register online now at <A
href="http://www.biotrinity.com/">www.biotrinity.com</A></P>
<P
style="FONT-SIZE: 0.7em; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left> </P>
<P
style="PADDING-RIGHT: 0px; FONT-SIZE: 0.7em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left>............................................................................................</P>
<H5
style="PADDING-LEFT: 5px; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left>BioTrinity sponsors</H5>
<P align=center><IMG height=63 alt=Stimutran
src="http://www.biotrinity.com/email/2008/sponsors/stimutran.gif"
width=100 border=0> </P>
<P align=center><IMG height=63 alt="Milton Park"
src="http://www.biotrinity.com/email/2008/sponsors/milton.gif"
width=100 border=0> 
<P align=center><IMG height=63 alt="UK Trade & Investment"
src="http://www.biotrinity.com/email/2008/sponsors/UKTI.gif"
width=100 border=0> <IMG height=63
alt="Merck Sharpe Dohme"
src="http://www.biotrinity.com/email/2008/sponsors/msd.gif"
width=100 border=0>  <IMG height=63 alt=genzyme
src="http://www.biotrinity.com/email/2008/sponsors/genzyme.gif"
width=100 border=0></P>
<P align=center> <IMG height=63 alt="Grant Thornton"
src="http://www.biotrinity.com/email/2008/sponsors/GT.gif" width=100
border=0> <IMG height=63 alt="Helvoet Pharma"
src="http://www.biotrinity.com/email/2008/sponsors/helvoet.gif"
width=100 border=0>   <IMG height=63 alt=SEHTA
src="http://www.biotrinity.com/email/2008/sponsors/sehta.gif"
width=100 border=0>
<P align=center>  <IMG height=63 alt="Thermo Fisher"
src="http://www.biotrinity.com/email/2008/sponsors/fisher.gif"
width=100 border=0>  <IMG height=63 alt=Thomson
src="http://www.biotrinity.com/email/2008/sponsors/thomson.gif"
width=100 border=0>  <IMG height=63 alt="De Facto"
src="http://www.biotrinity.com/email/2008/sponsors/defacto.gif"
width=100 border=0> </P>
<P align=center> <IMG height=63 alt=Manches
src="http://www.biotrinity.com/email/2008/sponsors/manches.gif"
width=100 border=0> <IMG height=63 alt=RDP
src="http://www.biotrinity.com/email/2008/sponsors/RDP.gif"
width=100 border=0> <IMG height=63
alt="Giles Insurance Brokers"
src="http://www.biotrinity.com/email/2008/sponsors/giles_100x63.jpg"
width=100 border=0>
<P align=center> <IMG height=63
alt="Biotechnology Finance Advisory Service"
src="http://www.biotrinity.com/email/2008/sponsors/BFAS_logo.gif"
width=100 border=0> <IMG height=63 alt="Pharma Ventures"
src="http://www.biotrinity.com/email/2008/sponsors/PharmaVcolour.gif"
width=100 border=0> </P>
<P
style="PADDING-RIGHT: 0px; FONT-SIZE: 0.7em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left>............................................................................................</P>
<H5
style="PADDING-LEFT: 5px; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left>BioTrinity partners</H5>
<P align=center><IMG height=63 alt=BioSpectrum
src="http://www.biotrinity.com/email/2008/partners/biospectrum.gif"
width=100 border=0> <IMG height=63
alt="Drug Discovery Today"
src="http://www.biotrinity.com/email/2008/partners/ddt.gif"
width=100 border=0>   <IMG height=63 alt=LBN
src="http://www.biotrinity.com/images/network_logos/lbn.jpg"
width=100 border=0>  </P>
<P align=center><IMG height=63 alt="European Biotechnology News"
src="http://www.biotrinity.com/email/2008/partners/EBN.gif"
width=100 border=0> <IMG height=63 alt=TVLSN
src="http://www.biotrinity.com/email/2008/partners/tvlsn.jpg"
width=100 border=0>  <IMG height=63 alt=BioProcessUK
src="http://www.biotrinity.com/email/2008/partners/bioprocessuk.gif"
width=100 border=0> </P>
<P align=center><IMG height=63 alt=Pharmalicensing
src="http://www.biotrinity.com/email/2008/partners/pharmalicensing.gif"
width=100 border=0>    <IMG height=63 alt=MedNous
src="http://www.biotrinity.com/images/mednous.jpg" width=100
border=0> </P>
<P
style="PADDING-RIGHT: 0px; FONT-SIZE: 0.7em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left>............................................................................................</P>
<H5
style="PADDING-LEFT: 5px; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left>BioTrinity is organised by OBN</H5>
<P align=center><A href="http://www.oxfordshirebioscience.com"><IMG
height=63 alt=OBN
src="http://www.biotrinity.com/email/2008/sponsors/obn_100x63.gif"
width=100 border=0></A> </P>
<P></P>
<P align=center> </P></TD></TR>
<TR></TR>
<TR>
<TD bgColor=#025273>
<P
style="FONT-SIZE: x-small; COLOR: #fff; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial,
sans-serif"
align=center>© 2006-2008 <A style="COLOR: #fff"
href="http://www.oxfordshirebioscience.com">OBN</A></P>
<P></P></TD></TR></TBODY></TABLE></TD></TR></TBODY></TABLE>
<!-- begin subscription_form_widget.tmpl -->
<form action="http://www.biotrinity.com/cgi-bin/dada/mail.cgi" method="post">
<fieldset>
<legend>
Subscribe/Unsubscribe on BioTrinity - Keep me informed
</legend>
<input type="hidden" name="list" value="premarketing" />
<p>
<label for="email" style="width: 7em;float: left;text-align: right;margin-right: 0.5em;display: block" >
Email Address:
</label>
<input type="text" name="email" id="email" value="" /> <span class="error">* Required</span>
</p>
<hr style="border-top: 1px solid black;" />
<p>
<label for="f_s" style="width: 7em;float: left;text-align: right;margin-right: 0.5em;display: block">
Subscribe
</label>
<input type="radio" name="f" id="f_s" value="subscribe" checked="checked" />
</p>
<p>
<label for="f_u" style="width: 7em;float: left;text-align: right;margin-right: 0.5em;display: block">Unsubscribe</label>
<input type="radio" name="f" id="f_u" value="unsubscribe" />
</p>
<hr style="border-top: 1px solid black;" />
<p style="text-align:right;display:block">
<input type="submit" value="Submit Your Information" class="processing" />
</p>
</fieldset>
</form>
<!-- end subscription_form_widget.tmpl -->
Exciting new VC firm to take part in Panel Discussion at BioTrinity 2008
tag:www.biotrinity.com,2008-04-03:%2Fcgi-bin%2Fdada%2Fmail.cgi%2Farchive%2Fpremarketing%2F20080403170356%2F
2008-04-03T17:03:56Z
2008-04-03T17:03:56Z
<TABLE
style="PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: 0px; WIDTH: 100%; PADDING-TOP: 0px; HEIGHT: 100%; BACKGROUND-COLOR: #002a3b">
<TBODY>
<TR>
<TD bgColor=#002a3b>
<TABLE borderColor=#ffffff cellSpacing=0 cellPadding=0 width=600
align=center bgColor=#ffffff border=0>
<TBODY>
<TR>
<TD bgColor=#002a3b><SPAN style="BACKGROUND-COLOR: #002a3b"><A
href="http://www.biotrinity.com" target=_blank></A></SPAN><BR></TD></TR>
<TR>
<TD>
<DIV align=center><A
href="http://www.biotrinity.com/registration.html"><IMG
src="http://biotrinity.com/images/email_logo.gif" border=0>
</A></DIV></TD></TR>
<TR>
<TD style="PADDING-LEFT: 5px; PADDING-BOTTOM: 10px" vAlign=top
rowSpan=2>
<P class=MsoNormal><B><FONT face=Arial color=#003366 size=2><SPAN
style="FONT-WEIGHT: bold; FONT-SIZE: 10pt; COLOR: #003366; FONT-FAMILY: Arial"><o:p></o:p></SPAN></FONT></B> </P>
<DIV align=center><IMG
src="http://biotrinity.com/email/negative_photo_strip.jpg"
border=0></DIV>
<P
style="PADDING-LEFT: 10px; FONT-SIZE: 1.2em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left>BioTrinity 2008 - Oxford, April 15-16, 2008
<P
style="PADDING-RIGHT: 10px; FONT-SIZE: 1.2em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=right>New VC to take part in Panel Discussion at BioTrinity
2008
<P
style="FONT-SIZE: 0.9em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left><STRONG>Orion Healthcare Equity Partners</STRONG> is an
exciting new international healtchare venture capital firm started
by experienced investors, some with links to the Oxford
BioCluster.  Zina Affas will represent Orion on the VC Panel
Discussion scheduled to take place on the morning of April 16th at
BioTrinity in Oxford. Zina was previously Life Sciences Partner at
Atlas Venture.</P>
<P
style="FONT-SIZE: 0.9em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left>Other key staff at Orion include Mark Carthy was key in
Massachusetts-based Oxford Bioscience Parner's financing of
Oxford-based PowderMed, and was a Non-Executive Director until its
acquisition by Pfizer in October 2006 for approximately £218m.</P>
<P
style="FONT-SIZE: 0.9em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left>In other additions to the programme David Phillips, SVP
at <STRONG>BioFocus DPI</STRONG> will be giving a keynotes on
"Building a leading European Biotechnology Company", including
details of the strategy behind BioFocus's ADR listing and AIM
de-listing undertaken earlier this year.</P>
<P
style="FONT-SIZE: 0.9em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left>Continuing BioTrinity's financing alternatives theme, we
are very pleased to announce participation by James Posnetts,
Managing Director European Products from <STRONG>NYSE
Euronext</STRONG></P>
<P
style="FONT-SIZE: 0.9em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left><SPAN class=style3> 
<TABLE>
<TBODY>
<TR>
<TD width=100></TD>
<TD>
<P
style="FONT-SIZE: 0.9em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left><IMG
src="http://www.biotrinity.com/images/tri.gif">Over
<STRONG>300</STRONG> delegates already confirmed<BR><IMG
src="http://www.biotrinity.com/images/tri.gif"><STRONG>215</STRONG> <A
href="http://www.biotrinity.com/companies_attending.html">companies</A>
already confirmed<BR><IMG
src="http://www.biotrinity.com/images/tri.gif"><STRONG>Over
1000</STRONG> partnering requests already made<BR><IMG
src="http://www.biotrinity.com/images/tri.gif">Nearly
<STRONG>100</STRONG> licensing opportunities already available
</P></TD></TR></TBODY></TABLE></SPAN></P>
<P
style="FONT-SIZE: 0.9em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left>VCs and investment-side companies active at BioTrinity
will include:</P>
<P
style="FONT-SIZE: 0.9em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left><STRONG>Abingworth</STRONG> - Tim Haines will be joining
the Financing Alternatives panel on Day One</P>
<P
style="FONT-SIZE: 0.9em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left><STRONG>SR One</STRONG> - Deborah Harland, General
Partner is partnering at BioTrinity (GSK corporate venturer)</P>
<P
style="FONT-SIZE: 0.9em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left><STRONG>Sofinnova</STRONG> - Graziano Seghezzi is
partnering and joining the VC Panel Discussion on Day Two</P>
<P
style="FONT-SIZE: 0.9em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left><STRONG>Oxford Capital Partners</STRONG> - David Mott,
Investment Director, is partnering, with Ted chairing the VC Panel
Discussion on Day Two</P>
<P
style="FONT-SIZE: 0.9em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left><STRONG>MP Healthcare Venture Management</STRONG> -
Jeffrey B Moore, VP, is partnering and joining the VC Panel
Discussion (Mitsubishi Pharma corporate venturer)</P>
<P
style="FONT-SIZE: 0.9em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left><STRONG>The Wellcome Trust</STRONG> - Richard Seabrook,
Head of  Business Development is partnering and joining the VC
Panel Discussion</P>
<P
style="FONT-SIZE: 0.9em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left><STRONG>NYSE Euronext</STRONG> - James Posnetts, MD of
European Products is chairing and partnering</P>
<P
style="FONT-SIZE: 0.9em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left><STRONG>Innovator Capital</STRONG> - Sanjeev Gogna,
Director of Corporate Finance is partnering</P>
<P
style="FONT-SIZE: 0.9em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left><STRONG>Beer and Partners</STRONG> - Lawrence Fenelon,
Associate, will be partnering for companies seeking angel
financing in the £75,000 and £5 million range</P>
<P
style="FONT-SIZE: 0.9em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left><STRONG>Catalyst Venture Partners</STRONG> - Richard
Turner, CEO,  will be partnering with early and growth
stage technology companies </P>
<P
style="FONT-SIZE: 0.9em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left><STRONG>Noble Fund Managers</STRONG> - Stephane Mery,
Director is partnering</P>
<P
style="FONT-SIZE: 0.9em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left><STRONG>CannacordAdams</STRONG> - Karl Keegan, MD is
partnering and chairing the Financing Alternatives panel from 11 AM
on April 15th</P>
<P
style="FONT-SIZE: 0.9em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left>Over 900 one-to-one meeting requests have been placed by
delegates in the BioTrinity partnering system, and over 300
delegates are confirmed from 215 companies already. </P>
<P
style="FONT-SIZE: 0.9em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left>You still do have time to register, but the longer you
leave it - the less time you have to use the partnering system
before the meeting,<BR>although we will be providing access to the
partnering system during the meeting.</P>
<P
style="FONT-SIZE: 0.9em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left>Can you afford to miss BioTrinity 2008? <FONT
face="Trebuchet MS"><A style="COLOR: #025273"
href="http://www.biotrinity.com/registration.html">Register online
now</A> </FONT></SPAN></FONT></B></P></SPAN><SPAN
class=style3></SPAN>
<P></P>
<H3
style="FONT-SIZE: small; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left><STRONG>Four key facts about BioTrinity 2008 -
Oxford</STRONG></H3>
<UL
style="FONT-SIZE: 0.7em; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif; LIST-STYLE-TYPE: circle">
<LI>
<DIV align=left>Largest <STRONG>biopartnering</STRONG> conference
in South-East England</DIV>
<LI>Partnering is <FONT color=#ff0000>live</FONT>: meeting
requests are climbing fast
<LI>
<DIV align=left>Uniquely your meetings will be held in private
rooms</DIV>
<LI>Pharmas attending: <STRONG>Takeda, Kowa, AstraZeneca, Merck,
Genzyme, Bristol-Myers Squib, Teba </STRONG>and<STRONG>
Shire</STRONG>
<LI>
<P
style="PADDING-RIGHT: 0px; FONT-SIZE: 0.7em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left><SPAN class=style3></SPAN></P><SPAN class=style3>The
<STRONG>updated programme</STRONG> for BioTrinity has now been
published online and can be downloaded: <A
href="http://www.biotrinity.com/programme.html">online programme</A>
</SPAN></LI></UL>
<P
style="PADDING-RIGHT: 0px; FONT-SIZE: 0.7em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=center>...........................................................................................</P>
<H3
style="FONT-SIZE: small; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left><STRONG>What other people think: </STRONG></H3>
<P
style="FONT-SIZE: 0.7em; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left><EM>"...I would like to congratulate you on an excellent
meeting.."</EM><BR>Tim Haines, Partner, <STRONG>Abingworth
Management</STRONG>
<P
style="FONT-SIZE: 0.7em; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left><EM>"...Congratulations on such a good event. I had a
very productive day with lots of organized and impromptu meetings -
a very worthwhile event for me." </EM>Dr Charles Potter, CEO,
<STRONG>Glide Pharma</STRONG>
<P
style="FONT-SIZE: 0.7em; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left>"<EM>I am delighted to be speaking at BioTrinity 2008,
which is an opportune platform on which we can discuss the recent
milestones achieved in the development of TroVax, our lead cancer
immunotherapy</EM>." Peter Nolan, SVP Commercial Development at
<STRONG>Oxford BioMedica</STRONG><BR>
<P
style="PADDING-RIGHT: 10px; FONT-SIZE: 0.7em; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=right><A
href="http://www.biotrinity.com/testimonials.html">Read
testimonials...</A><BR>
<P
style="PADDING-RIGHT: 0px; FONT-SIZE: 0.7em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=center>...........................................................................................</P>
<P
style="FONT-SIZE: 0.7em; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left>Register now and start partnering:<A
href="http://www.biotrinity.com/">www.biotrinity.com</A>
<P
style="PADDING-RIGHT: 0px; FONT-SIZE: 0.7em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left><A
href="http://www.partneringgate.com/reg/reg_form.php?id=3244f$b7trFN6q5zTQo&regtype=7344f$b7e9fTFw2a6rc"><IMG
height=88 alt="Register online now! www.biotrinity.com"
src="http://www.biotrinity.com/email/2008/register2.jpg" width=205
border=0></A>
<P
style="PADDING-RIGHT: 0px; FONT-SIZE: 0.7em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=center>............................................................................................</P>
<H4
style="COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left>Contact details:</H4>
<P
style="FONT-SIZE: 0.7em; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left>Jon Rees, Network Director, OBN <BR>Suite L, Park House
<BR>11 Milton Park, Abingdon<BR>Oxfordshire OX14 4RA<BR>Tel. +44 (0)
1865 594640<BR>Fax. +44 (0) 1235 835843<BR><A style="COLOR: #025273"
href="mailto:jon.rees@oxfordshirebioscience.net">jon.rees@oxfordshirebioscience.net</A></P><BR>
<P
style="PADDING-RIGHT: 0px; FONT-SIZE: 0.9em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=center>Register online now at <A
href="http://www.biotrinity.com/">www.biotrinity.com</A></P>
<P
style="FONT-SIZE: 0.7em; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left> </P>
<P
style="PADDING-RIGHT: 0px; FONT-SIZE: 0.7em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left>............................................................................................</P>
<H5
style="PADDING-LEFT: 5px; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left>BioTrinity sponsors</H5>
<P align=center><IMG height=63 alt=Stimutran
src="http://www.biotrinity.com/email/2008/sponsors/stimutran.gif"
width=100 border=0> </P>
<P align=center><IMG height=63 alt="Milton Park"
src="http://www.biotrinity.com/email/2008/sponsors/milton.gif"
width=100 border=0> 
<P align=center><IMG height=63 alt="UK Trade & Investment"
src="http://www.biotrinity.com/email/2008/sponsors/UKTI.gif"
width=100 border=0> <IMG height=63
alt="Merck Sharpe Dohme"
src="http://www.biotrinity.com/email/2008/sponsors/msd.gif"
width=100 border=0>  <IMG height=63 alt=genzyme
src="http://www.biotrinity.com/email/2008/sponsors/genzyme.gif"
width=100 border=0></P>
<P align=center> <IMG height=63 alt="Grant Thornton"
src="http://www.biotrinity.com/email/2008/sponsors/GT.gif" width=100
border=0> <IMG height=63 alt="Helvoet Pharma"
src="http://www.biotrinity.com/email/2008/sponsors/helvoet.gif"
width=100 border=0>   <IMG height=63 alt=SEHTA
src="http://www.biotrinity.com/email/2008/sponsors/sehta.gif"
width=100 border=0>
<P align=center>  <IMG height=63 alt="Thermo Fisher"
src="http://www.biotrinity.com/email/2008/sponsors/fisher.gif"
width=100 border=0>  <IMG height=63 alt=Thomson
src="http://www.biotrinity.com/email/2008/sponsors/thomson.gif"
width=100 border=0>  <IMG height=63 alt="De Facto"
src="http://www.biotrinity.com/email/2008/sponsors/defacto.gif"
width=100 border=0> </P>
<P align=center> <IMG height=63 alt=Manches
src="http://www.biotrinity.com/email/2008/sponsors/manches.gif"
width=100 border=0> <IMG height=63 alt=RDP
src="http://www.biotrinity.com/email/2008/sponsors/RDP.gif"
width=100 border=0> <IMG height=63
alt="Giles Insurance Brokers"
src="http://www.biotrinity.com/email/2008/sponsors/giles_100x63.jpg"
width=100 border=0>
<P align=center> <IMG height=63
alt="Biotechnology Finance Advisory Service"
src="http://www.biotrinity.com/email/2008/sponsors/BFAS_logo.gif"
width=100 border=0> <IMG height=63 alt="Pharma Ventures"
src="http://www.biotrinity.com/email/2008/sponsors/PharmaVcolour.gif"
width=100 border=0> </P>
<P
style="PADDING-RIGHT: 0px; FONT-SIZE: 0.7em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left>............................................................................................</P>
<H5
style="PADDING-LEFT: 5px; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left>BioTrinity partners</H5>
<P align=center><IMG height=63 alt=BioSpectrum
src="http://www.biotrinity.com/email/2008/partners/biospectrum.gif"
width=100 border=0> <IMG height=63
alt="Drug Discovery Today"
src="http://www.biotrinity.com/email/2008/partners/ddt.gif"
width=100 border=0>   <IMG height=63 alt=LBN
src="http://www.biotrinity.com/images/network_logos/lbn.jpg"
width=100 border=0>  </P>
<P align=center><IMG height=63 alt="European Biotechnology News"
src="http://www.biotrinity.com/email/2008/partners/EBN.gif"
width=100 border=0> <IMG height=63 alt=TVLSN
src="http://www.biotrinity.com/email/2008/partners/tvlsn.jpg"
width=100 border=0>  <IMG height=63 alt=BioProcessUK
src="http://www.biotrinity.com/email/2008/partners/bioprocessuk.gif"
width=100 border=0> </P>
<P align=center><IMG height=63 alt=Pharmalicensing
src="http://www.biotrinity.com/email/2008/partners/pharmalicensing.gif"
width=100 border=0>    <IMG height=63 alt=MedNous
src="http://www.biotrinity.com/images/mednous.jpg" width=100
border=0> </P>
<P
style="PADDING-RIGHT: 0px; FONT-SIZE: 0.7em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left>............................................................................................</P>
<H5
style="PADDING-LEFT: 5px; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left>BioTrinity is organised by OBN</H5>
<P align=center><A href="http://www.oxfordshirebioscience.com"><IMG
height=63 alt=OBN
src="http://www.biotrinity.com/email/2008/sponsors/obn_100x63.gif"
width=100 border=0></A> </P>
<P></P>
<P align=center> </P></TD></TR>
<TR></TR>
<TR>
<TD bgColor=#025273>
<P
style="FONT-SIZE: x-small; COLOR: #fff; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial,
sans-serif"
align=center>© 2006-2008 <A style="COLOR: #fff"
href="http://www.oxfordshirebioscience.com">OBN</A></P>
<P></P></TD></TR></TBODY></TABLE></TD></TR></TBODY></TABLE>
<!-- begin subscription_form_widget.tmpl -->
<form action="http://www.biotrinity.com/cgi-bin/dada/mail.cgi" method="post">
<fieldset>
<legend>
Subscribe/Unsubscribe on BioTrinity - Keep me informed
</legend>
<input type="hidden" name="list" value="premarketing" />
<p>
<label for="email" style="width: 7em;float: left;text-align: right;margin-right: 0.5em;display: block" >
Email Address:
</label>
<input type="text" name="email" id="email" value="" /> <span class="error">* Required</span>
</p>
<hr style="border-top: 1px solid black;" />
<p>
<label for="f_s" style="width: 7em;float: left;text-align: right;margin-right: 0.5em;display: block">
Subscribe
</label>
<input type="radio" name="f" id="f_s" value="subscribe" checked="checked" />
</p>
<p>
<label for="f_u" style="width: 7em;float: left;text-align: right;margin-right: 0.5em;display: block">Unsubscribe</label>
<input type="radio" name="f" id="f_u" value="unsubscribe" />
</p>
<hr style="border-top: 1px solid black;" />
<p style="text-align:right;display:block">
<input type="submit" value="Submit Your Information" class="processing" />
</p>
</fieldset>
</form>
<!-- end subscription_form_widget.tmpl -->
Oxford BioMedica develops strategic development plan with the commercialisation of TroVax
tag:www.biotrinity.com,2008-03-25:%2Fcgi-bin%2Fdada%2Fmail.cgi%2Farchive%2Fpremarketing%2F20080325104819%2F
2008-03-25T10:48:19Z
2008-03-25T10:48:19Z
<TABLE
style="PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: 0px; WIDTH: 100%; PADDING-TOP: 0px; HEIGHT: 100%; BACKGROUND-COLOR: #002a3b">
<TBODY>
<TR>
<TD bgColor=#002a3b>
<TABLE borderColor=#ffffff cellSpacing=0 cellPadding=0 width=600
align=center bgColor=#ffffff border=0>
<TBODY>
<TR>
<TD bgColor=#002a3b><SPAN style="BACKGROUND-COLOR: #002a3b"><A
href="http://www.biotrinity.com" target=_blank></A></SPAN><BR></TD></TR>
<TR>
<TD>
<DIV align=center><A
href="http://www.biotrinity.com/registration.html"><IMG
src="http://biotrinity.com/images/email_logo.gif" border=0>
</A></DIV></TD></TR>
<TR>
<TD style="PADDING-LEFT: 5px; PADDING-BOTTOM: 10px" vAlign=top
rowSpan=2>
<P class=MsoNormal><B><FONT face=Arial color=#003366 size=2><SPAN
style="FONT-WEIGHT: bold; FONT-SIZE: 10pt; COLOR: #003366; FONT-FAMILY: Arial"><o:p></o:p></SPAN></FONT></B> </P>
<DIV align=center><IMG
src="http://biotrinity.com/email/negative_photo_strip.jpg"
border=0></DIV>
<P
style="PADDING-LEFT: 10px; FONT-SIZE: 1.2em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left>BioTrinity 2008 - Oxford, April 15-16, 2008
<P
style="PADDING-RIGHT: 10px; FONT-SIZE: 1.2em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=right>South-East's Largest Biopartnering Conference and
Showcase
<P
style="FONT-SIZE: 0.9em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left>OBN invites you to participate in BioTrinity, the
South-East England’s equivalent of the ERBI BioExchange. With
just a few weeks to go before BioTrinity 2008 can you
afford to be missing from the list of nearly 200 companies
<EM>already</EM> confirmed for April 15-16 in Oxford? </P>
<P
style="FONT-SIZE: 0.9em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=center><FONT face="Trebuchet MS"><STRONG><EM><FONT
color=#ff0000>Partnering is live!</FONT></EM> </STRONG><A
style="COLOR: #025273"
href="http://www.biotrinity.com/registration.html">Register online
now</A> </FONT></SPAN></FONT></B></P></SPAN><SPAN class=style3>
<TABLE>
<TBODY>
<TR>
<TD width=100></TD>
<TD>
<P
style="FONT-SIZE: 0.9em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left><IMG
src="http://www.biotrinity.com/images/tri.gif"><STRONG>267</STRONG>
delegates already confirmed<BR><IMG
src="http://www.biotrinity.com/images/tri.gif"><STRONG>196</STRONG>
<A
href="http://www.biotrinity.com/companies_attending.html">companies</A>
already confirmed<BR><IMG
src="http://www.biotrinity.com/images/tri.gif"><STRONG>Hundreds</STRONG>
of partnering requests already made<BR><IMG
src="http://www.biotrinity.com/images/tri.gif"><STRONG>81</STRONG>
licensing opportunities already available
</P></TD></TR></TBODY></TABLE></SPAN>
<P
style="PADDING-RIGHT: 0px; FONT-SIZE: 0.7em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=center>...........................................................................................</P>
<H3
style="PADDING-LEFT: 10px; FONT-SIZE: small; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left><STRONG></STRONG>Oxford BioMedica develops strategic
development plan with the commercialisation of TroVax</H3>
<P
style="PADDING-RIGHT: 10px; PADDING-LEFT: 10px; FONT-SIZE: 0.9em; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left>  BioTrinity 2008 - Oxford announces a highly
relevant new addition to its programme. Oxfordshire Bioscience
Networks' leading partnering and networking event confirmed that
Peter Nolan, SVP Commercial Development at Oxford BioMedica, will
discuss the company's deal with sanofi-aventis to develop and
commercialise TroVax® for the treatment and prevention of cancers.
This follows the announcement that the TRIST trial successfully
completed patient enrolment.
<P
style="PADDING-RIGHT: 10px; PADDING-LEFT: 10px; FONT-SIZE: 0.9em; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left>  TroVax® is Oxford BioMedica's lead cancer
immunotherapy. Based on the broad distribution of the 5T4 tumour
antigen, TroVax® has potential application in a wide range of solid
tumours, including renal, colorectal, lung, breast and prostate
cancer. Earlier this month Oxford BioMedica announced that it has
successfully completed patient enrolment in the Phase III TRIST
study.
<P
style="PADDING-RIGHT: 10px; PADDING-LEFT: 10px; FONT-SIZE: 0.9em; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left>  690 patients have been randomised to-date and a
sufficient number of additional patients are being screened for
inclusion such that the total enrolment is expected to slightly
exceed the target of 700 patients. Over 100 sites in the USA,
European Union and Eastern Europe have recruited patients into the
trial. The trial started in November 2006; recruitment has been
completed on schedule and final results from the study are
anticipated in the first half of 2009.
<P
style="PADDING-RIGHT: 10px; PADDING-LEFT: 10px; FONT-SIZE: 0.9em; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left>  Peter Nolan commented <EM>"I am delighted to be
speaking at BioTrinity 2008, which is an opportune platform on which
we can discuss the recent milestones achieved in the development of
TroVax, our lead cancer immunotherapy."</EM>
<P
style="PADDING-RIGHT: 10px; PADDING-LEFT: 10px; FONT-SIZE: 0.9em; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left>  BioTrinity 2008 is taking place on April 15-16,
2008 in Oxford, UK and provides the opportunity to view the latest
presentations from the most promising companies within the UK's most
successful biotech super-cluster in Oxford and the South East of
England.
<P
style="PADDING-RIGHT: 0px; FONT-SIZE: 0.7em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=center>...........................................................................................</P>
<P
style="FONT-SIZE: 0.7em; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left>Register now and start partnering: <A
href="http://www.partneringgate.com/registration.php?id=3244f$b7trFN6q5zTQo&regtype=7344f$b7e9fTFw2a6rc">www.biotrinity.com</A>
<P
style="PADDING-RIGHT: 0px; FONT-SIZE: 0.7em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left><A
href="http://www.partneringgate.com/registration.php?id=3244f$b7trFN6q5zTQo&regtype=7344f$b7e9fTFw2a6rc"><IMG
height=88 alt="Register online now! www.biotrinity.com"
src="http://www.biotrinity.com/email/2008/register2.jpg" width=205
border=0></A>
<P
style="PADDING-RIGHT: 0px; FONT-SIZE: 0.7em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=center>............................................................................................</P>
<H4
style="COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left>Contact details:</H4>
<P
style="FONT-SIZE: 0.7em; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left>Jon Rees, Network Director, OBN <BR>Suite L, Park House
<BR>11 Milton Park, Abingdon<BR>Oxfordshire OX14 4RA<BR>Tel. +44 (0)
1865 594640<BR>Fax. +44 (0) 1235 835843<BR><A style="COLOR: #025273"
href="mailto:jon.rees@oxfordshirebioscience.net">jon.rees@oxfordshirebioscience.net</A></P><BR>
<P
style="PADDING-RIGHT: 0px; FONT-SIZE: 0.9em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=center>Register online now at <A
href="http://www.biotrinity.com/">www.biotrinity.com</A></P>
<P
style="FONT-SIZE: 0.7em; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left> </P>
<P
style="PADDING-RIGHT: 0px; FONT-SIZE: 0.7em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left>............................................................................................</P>
<H5
style="PADDING-LEFT: 5px; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left>BioTrinity sponsors</H5>
<P align=center><IMG height=63 alt=Stimutran
src="http://www.biotrinity.com/email/2008/sponsors/stimutran.gif"
width=100 border=0> </P>
<P align=center><IMG height=63 alt="Milton Park"
src="http://www.biotrinity.com/email/2008/sponsors/milton.gif"
width=100 border=0> 
<P align=center><IMG height=63 alt="UK Trade & Investment"
src="http://www.biotrinity.com/email/2008/sponsors/UKTI.gif"
width=100 border=0> <IMG height=63
alt="Merck Sharpe Dohme"
src="http://www.biotrinity.com/email/2008/sponsors/msd.gif"
width=100 border=0>  <IMG height=63 alt=genzyme
src="http://www.biotrinity.com/email/2008/sponsors/genzyme.gif"
width=100 border=0></P>
<P align=center> <IMG height=63 alt="Grant Thornton"
src="http://www.biotrinity.com/email/2008/sponsors/GT.gif" width=100
border=0> <IMG height=63 alt="Helvoet Pharma"
src="http://www.biotrinity.com/email/2008/sponsors/helvoet.gif"
width=100 border=0>   <IMG height=63 alt=SEHTA
src="http://www.biotrinity.com/email/2008/sponsors/sehta.gif"
width=100 border=0>
<P align=center>  <IMG height=63 alt="Thermo Fisher"
src="http://www.biotrinity.com/email/2008/sponsors/fisher.gif"
width=100 border=0>  <IMG height=63 alt=Thomson
src="http://www.biotrinity.com/email/2008/sponsors/thomson.gif"
width=100 border=0>  <IMG height=63 alt="De Facto"
src="http://www.biotrinity.com/email/2008/sponsors/defacto.gif"
width=100 border=0> </P>
<P align=center> <IMG height=63 alt=Manches
src="http://www.biotrinity.com/email/2008/sponsors/manches.gif"
width=100 border=0> <IMG height=63 alt=RDP
src="http://www.biotrinity.com/email/2008/sponsors/RDP.gif"
width=100 border=0> <IMG height=63
alt="Giles Insurance Brokers"
src="http://www.biotrinity.com/email/2008/sponsors/giles_100x63.jpg"
width=100 border=0>
<P align=center> <IMG height=63
alt="Biotechnology Finance Advisory Service"
src="http://www.biotrinity.com/email/2008/sponsors/BFAS_logo.gif"
width=100 border=0> <IMG height=63 alt="Pharma Ventures"
src="http://www.biotrinity.com/email/2008/sponsors/PharmaVcolour.gif"
width=100 border=0> </P>
<P
style="PADDING-RIGHT: 0px; FONT-SIZE: 0.7em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left>............................................................................................</P>
<H5
style="PADDING-LEFT: 5px; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left>BioTrinity partners</H5>
<P align=center><IMG height=63 alt=BioSpectrum
src="http://www.biotrinity.com/email/2008/partners/biospectrum.gif"
width=100 border=0> <IMG height=63
alt="Drug Discovery Today"
src="http://www.biotrinity.com/email/2008/partners/ddt.gif"
width=100 border=0>   <IMG height=63 alt=LBN
src="http://www.biotrinity.com/images/network_logos/lbn.jpg"
width=100 border=0>  </P>
<P align=center><IMG height=63 alt="European Biotechnology News"
src="http://www.biotrinity.com/email/2008/partners/EBN.gif"
width=100 border=0> <IMG height=63 alt=TVLSN
src="http://www.biotrinity.com/email/2008/partners/tvlsn.jpg"
width=100 border=0>  <IMG height=63 alt=BioProcessUK
src="http://www.biotrinity.com/email/2008/partners/bioprocessuk.gif"
width=100 border=0> </P>
<P align=center><IMG height=63 alt=Pharmalicensing
src="http://www.biotrinity.com/email/2008/partners/pharmalicensing.gif"
width=100 border=0> </P>
<P
style="PADDING-RIGHT: 0px; FONT-SIZE: 0.7em; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left>............................................................................................</P>
<H5
style="PADDING-LEFT: 5px; COLOR: #025273; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial, sans-serif"
align=left>BioTrinity is organised by OBN</H5>
<P align=center><A href="http://www.oxfordshirebioscience.com"><IMG
height=63 alt=OBN
src="http://www.biotrinity.com/email/2008/sponsors/obn_100x63.gif"
width=100 border=0></A> </P>
<P></P>
<P align=center> </P></TD></TR>
<TR></TR>
<TR>
<TD bgColor=#025273>
<P
style="FONT-SIZE: x-small; COLOR: #fff; FONT-FAMILY: Trebuchet MS, Verdana, Helvetica, Arial,
sans-serif"
align=center>© 2006-2008 <A style="COLOR: #fff"
href="http://www.oxfordshirebioscience.com">OBN</A></P>
<P></P></TD></TR></TBODY></TABLE></TD></TR></TBODY></TABLE>
<!-- begin subscription_form_widget.tmpl -->
<form action="http://www.biotrinity.com/cgi-bin/dada/mail.cgi" method="post">
<fieldset>
<legend>
Subscribe/Unsubscribe on BioTrinity - Keep me informed
</legend>
<input type="hidden" name="list" value="premarketing" />
<p>
<label for="email" style="width: 7em;float: left;text-align: right;margin-right: 0.5em;display: block" >
Email Address:
</label>
<input type="text" name="email" id="email" value="" /> <span class="error">* Required</span>
</p>
<hr style="border-top: 1px solid black;" />
<p>
<label for="f_s" style="width: 7em;float: left;text-align: right;margin-right: 0.5em;display: block">
Subscribe
</label>
<input type="radio" name="f" id="f_s" value="subscribe" checked="checked" />